Ed Torr, Independent Non-Executive Chairman
Appointment:
Ed was appointed to the Board in 2017 and was appointed Chairman on 20 June 2024 following Jan Boone’s resignation.
Committee membership:
Member of the Audit & Risk Committee and member of the Remuneration & Nomination Committee.
Relevant skills and experience:
As Chair, Ed brings significant experience of business development and product development in the animal health sector.
He was part of the management buyout team that set up Dechra Veterinary Products in 1997 and an Executive Director on the board of Dechra Pharmaceuticals plc from 2000 until 2013, responsible for business development and managing the European business unit and instrumental in setting up the US business. Since 2014, Ed has independently advised various companies on sales and marketing structures, M&A opportunities, “in” and “out” licensing of products and investment opportunities within the veterinary and animal health sector.
Key external appointments:
Ed was a Non-Executive Director of Intervacc AB, a Swedish biotechnology company listed on Nasdaq Stockholm, until 23 November 2023.
